STAT
SEPTEMBER 6, 2024
Food and Drug Administration data shows that agency staffers have not returned to roughly 2,000 pharmaceutical manufacturing firms to conduct surveillance inspections since before the pandemic, raising the risks of contamination and other issues in drugs used by millions of Americans. An analysis of U.S.
European Pharmaceutical Review
NOVEMBER 10, 2023
Novo Nordisk’s Denmark manufacturing facilities Currently, Novo Nordisk’s Kalundborg production facilities manufacture products for treating obesity and diabetes as well as several biopharmaceutical products, employing around 4,400 employees. In June 2023, the company announced its plans to invest €2.1
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
OCTOBER 17, 2022
Sanofi has signed definitive agreements with Adragos Pharmaceutical, a German contract development and manufacturing organisation (CDMO), for the sale of its pharmaceutical manufacturing site in Kawagoe, Japan. The French pharmaceutical company will also enter into a long-term supply agreement with the CDMO.
Express Pharma
MARCH 16, 2025
What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceutical manufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands.
pharmaphorum
FEBRUARY 15, 2022
The findings point to a “threat to environmental and global health,” say the scientists, who found that paracetamol, antibiotics epilepsy drug carbamazepine, metformin for diabetes and other compounds like caffeine and nicotine were found in samples from around the world – including in Antarctica.
Pharmaceutical Technology
APRIL 18, 2023
Lilly chair and CEO Dave Ricks said: “Through these new facilities, Hoosiers [workers from the state of Indiana] will make life-changing medicines that patients around the world need to address serious health challenges, including diabetes and cancer. “We’re Last year, the company committed to providing $42.5m
pharmaphorum
JULY 28, 2022
The pandemic effectively shut down supply chain paths overnight, and as a result, pharmaceutical manufacturers have faced delays and bottlenecks, which have caused drug shortages in healthcare systems. A break in the supply chain could have enormous implications for millions of people suffering from these conditions.
Expert insights. Personalized for you.
257 
Let's personalize your content